Skip to main content
    6

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.53
    +0.04 (+8.14%)

    Market Cap: $1.74M

    Last updated: Nov 17, 2026 at 4:24 PM ET

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a market cap of $1.74M and an enterprise value of $1.43M. It kept -825.05% of revenue as net income over the last 12 months. Revenue fell 27.45% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 17.63% below the market cap, as cash exceeds debt.

    Market Cap$1.74M
    Enterprise Value$1.43M
    Latest price (Nov 17, 2026)$0.53

    Key Dates

    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 33.90% in the quarter ended Sep 30, 2026.

    Shares Outstanding3.55M
    Shares Change (QoQ)+33.90%

    Valuation Ratios

    The price to sales ratio is 1.9x.

    P/S Ratio1.9x
    Forward P/S1.7x

    Price Statistics

    The stock is down 85.33% over 52 weeks and trades 42.39% below its 50-day average.

    Beta (1Y)1.59
    52-Week Change-85.33%
    1-Month Change-35.44%
    3-Month Change-52.73%
    6-Month Change-62.12%
    Total Return (1Y)-85.33%
    Total Return (3Y CAGR)-85.26%
    Max Drawdown (1Y)-90.50%
    Max Drawdown (3Y)-99.83%
    Sharpe Ratio (1Y)-1.31
    Correlation with SPY (1Y)0.14
    50-Day Average$0.92
    200-Day Average$1.59
    52-Week Range$0.48 to $5.30
    RSI (14 Days)33.2
    Average Volume (20 Days)1.00M

    Price chart

    Financial Position

    Current assets cover 1.17x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.17x
    Quick Ratio0.91x
    Debt / Equity0.00x
    Interest Coverage-1143.56x

    Returns and Efficiency

    Return on equity is -991.94% and return on assets is -269.94% over the last 12 months.

    Return on Equity (ROE)-991.94%
    Return on Assets (ROA)-269.94%
    Return on Capital Employed (ROCE)-924.64%
    Asset Turnover0.21x
    Inventory Turnover0.95x
    Receivables Turnover2.24x
    Cash Conversion Cycle-244 days

    Scores

    SXTP has an Altman Z-Score of -32.74, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-32.74
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $1.01M over the last 12 months.

    Revenue$1.01M
    Revenue Growth (YoY)-27.45%
    Gross Profit$621.97K
    Operating Income-$8.81M
    Pretax Income-$8.35M
    Net Income-$8.35M
    EBITDA-$8.09M
    EBIT-$8.35M
    Reported EPS (TTM)-$11.03

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.25% of the $3.09M in total assets.

    Cash and Equivalents$306.19K
    Total Debt$0
    Net Cash$306.19K
    Net Cash Per Share$0.09
    Working Capital$372.87K
    Shareholder Equity$842.02K
    Tangible Book Value$537.99K
    Total Assets$3.09M
    Total Liabilities$2.34M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$8.11M
    FCF Per Share-$2.34
    Depreciation and Amortization$256.36K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -870.39%.

    Gross Margin61.44%
    Operating Margin-870.39%
    Pretax Margin-825.23%
    Net Margin-825.05%
    EBITDA Margin-799.19%
    EBIT Margin-824.51%
    Gross Margin (5Y Average)-2.67%

    Growth

    Revenue grew 40.21% a year over 3 years.

    Revenue Growth (3Y CAGR)+40.21%
    Revenue Growth (5Y CAGR)-8.37%

    Revenue and profit by year

    Dividends and Yields

    SXTP does not pay a dividend.

    Buyback Yield-240.69%
    Shareholder Yield-240.69%

    Stock Splits

    The last split was a 1-for-4 reverse split on Jan 20, 2026.

    Last Split DateJan 20, 2026
    Split TypeReverse split
    Split Ratio1:4

    Peer Position

    Against 4 similar companies, SXTP has the 4th highest P/S.

    P/S Ratio1.9x vs 29.2x median
    Revenue Growth (Trailing 4 Quarters, YoY)-27.45% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 9.84% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+9.84%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SXTP

    What is SXTP's market cap?

    60 Degrees Pharmaceuticals, Inc. Common Stock has a market cap of $1.74M. Its enterprise value, which adds debt and subtracts cash, is $1.43M.

    How many shares of SXTP are outstanding?

    60 Degrees Pharmaceuticals, Inc. Common Stock has 3.55M shares outstanding.

    Does SXTP pay a dividend?

    No. 60 Degrees Pharmaceuticals, Inc. Common Stock does not pay a dividend.

    How much debt does SXTP have?

    60 Degrees Pharmaceuticals, Inc. Common Stock has $0 of total debt and $306.19K of cash and equivalents, a net cash position of $306.19K.